A US-based private equity fund investing in innovative companies addressing significant unmet medical needs.
At 108 BioCapital, we are dedicated to advancing the frontiers of medical innovation. Our mission is to invest in transformative healthcare solutions that address urgent unmet medical needs, improve patient outcomes, and deliver sustained value to our investors.
The US healthcare and medtech sectors present an extraordinary growth opportunity, with healthcare spending projected to reach 20% of GDP by 2032.
Our leadership team combines deep scientific expertise, investment acumen, and operational experience. From groundbreaking biotech innovations to successful exits exceeding billions in value creation, our team is uniquely positioned to identify, nurture, and scale high-potential opportunities in the medtech and biotech sectors.
The information on this website is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Investments are offered only to accredited investors through a confidential private placement memorandum and related documents. All investments involve risk, including the possible loss of principal. Past performance is not indicative of future results.
© 108 BioCapital Growth Stage Fund. All rights reserved.
